Form 4 for CI Cigna
Accepted 2025-03-04 00:00:00 ET · period of report 2025-02-28 · accession 0001225208-25-002922 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-04 | 2025-02-28 | CI | Cordani David | COB, CEO, Dir | A - Grant | $0.00 | +60.6K | 170.8K | +55% | $0 |
| D | 2025-03-04 | 2025-03-03 | CI | Cordani David | COB, CEO, Dir | S - Sale | $308.12 | -26.5K | 127.8K | -17% | -$8.17M |
| DM | 2025-03-04 | 2025-02-28 | CI | Cordani David | COB, CEO, Dir | F - Tax | $305.86 | -27.6K | 177.2K | -13% | -$8.44M |
| D | 2025-03-04 | 2025-02-28 | CI | Cordani David | COB, CEO, Dir | A - Grant | $0.00 | +39.5K | 39.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.01 Par Value | 2025-02-28 | A | A | 11,117 | $0.00 | 181,900 | D | — | — | (F3) These restricted shares vest in three equal annual installments beginning March 1, 2026. |
| 2 | Common | Common Stock, $.01 Par Value | 2025-03-03 | S | D | 26,527 | $308.12 | 127,767 | D | — | — | |
| 3 | Common | Common Stock, $.01 Par Value | 2025-02-28 | F | D | 22,910 | $305.86 | 154,294 | D | — | — | (F5) Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. |
| 4 | Common | Common Stock, $.01 Par Value | 2025-02-28 | F | D | 4,696 | $305.86 | 177,204 | D | — | — | (F4) Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. |
| 5 | Common | Common Stock, $.01 Par Value | 2025-02-28 | A | A | 49,437 | $0.00 | 170,783 | D | — | — | (F1) The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. (F2) Reflects the transfer by the Reporting Person of 334,387 shares of common stock on May 8, 2024 to the Reporting Person's grantor retained annuity trust. In addition, it reflects the transfer by the Reporting Person's grantor retained annuity trust of 99,918 shares of common stock on January 27, 2025 in respect of a payment of an annual annuity to the Reporting Person pursuant to the terms of the grantor retained annuity trust. |
| 6 | Derivative | Employee Stock Option (Right to Buy) | 2025-02-28 | A | A | 39,476 | $0.00 | 39,476 | D | $305.86 · 2026-03-01 to 2035-02-28 | 39,476 Common Stock, $.01 Par Value | (F8) This option vests in three equal annual installments beginning March 1, 2026. |